Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)
Clinical trial NCT03577899 · TERMINATED
Trial details
- NCT number
- NCT03577899
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2020-09-25
- Enrollment
- 1157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.